John H Contois

Summary

Publications

  1. ncbi Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
    John H Contois
    Maine Standards Company, Windham, ME 04062, USA
    Clin Chem 55:407-19. 2009
  2. ncbi Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    John H Contois
    Maine Standards Company, 765 Roosevelt Trail, Windham, ME 04062, USA
    J Clin Lipidol 5:264-72. 2011

Detail Information

Publications2

  1. ncbi Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
    John H Contois
    Maine Standards Company, Windham, ME 04062, USA
    Clin Chem 55:407-19. 2009
    ..Low-density lipoprotein cholesterol (LDL-C) has been the cornerstone measurement for assessing cardiovascular risk for nearly 20 years...
  2. ncbi Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
    John H Contois
    Maine Standards Company, 765 Roosevelt Trail, Windham, ME 04062, USA
    J Clin Lipidol 5:264-72. 2011
    ..Apolipoprotein B appears to provide a more reliable alternative, but assays for it have not been as rigorously tested as direct LDL-C and HDL-C assays...